WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Join the Society for Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helton, T. D.
Right arrow Articles by Horne, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helton, T. D.
Right arrow Articles by Horne, W. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 1, 2002, 22(21):9331-9339

Alternative Splicing of a beta 4 Subunit Proline-Rich Motif Regulates Voltage-Dependent Gating and Toxin Block of Cav2.1 Ca2+ Channels

Thomas D. Helton1, Douglas J. Kojetin2, John Cavanagh2, and William A. Horne1

Departments of 1 Molecular Biomedical Sciences and 2 Molecular and Structural Biochemistry, North Carolina State University, Raleigh, North Carolina 27606


    ABSTRACT

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Ca2+ channel beta  subunits modify alpha 1 subunit gating properties through direct interactions with intracellular linker domains. In a previous report (Helton and Horne, 2002), we showed that alternative splicing of the beta 4 subunit had alpha 1 subunit subtype-specific effects on Ca2+ channel activation and fast inactivation. We extend these findings in the present report to include effects on slow inactivation and block by the peptide toxin omega -conotoxin (CTx)-MVIIC. N-terminal deletion and site-directed mutagenesis experiments revealed that the effects of alternative splicing on toxin block and all aspects of gating could be attributed to a proline-rich motif found within N-terminal beta 4b amino acids 10-20. Interestingly, this motif is conserved within the third postsynaptic density-95 (PSD-95)/Discs large/zona occludens-1 domain of the distantly related membrane-associated guanylate kinase homolog, PSD-95. Sequence identity of ~30% made possible the building of beta 4a and beta 4b three-dimensional structural models using PSD-95 as the target sequence. The models (1) reveal that alternative splicing of the beta 4 N terminus results in dramatic differences in surface charge distribution and (2) localize the proline-rich motif of beta 4b to an extended arm structure that flanks what would be the equivalent of a highly modified PSD-95 carboxylate binding loop. Northern blot analysis revealed a markedly different pattern of distribution for beta 4a versus beta 4b in the human CNS. Whereas beta 4a is distributed throughout evolutionarily older regions of the CNS, beta 4b is concentrated heavily in the forebrain. These results raise interesting questions about the functional role that alternative splicing of the beta 4 subunit has played in the evolution of complex neural networks.

Key words: calcium channel; beta 4 subunit; PSD-95; alternative splicing; gating; N terminus; omega -CTx-MVIIC


    INTRODUCTION

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Voltage-gated Ca2+ channels participate in an extensive array of cellular activities including excitation-contraction coupling, transcription, and neurotransmitter release. Neuronal Cav2 channels are assemblies of up to five subunits, alpha 1, alpha 2/delta , beta , and gamma . The alpha 1 subunit consists of four homologous repeats (I-IV) of six helices (S1-S6) that arrange to form the selectivity filter and pore. The 24 transmembrane helices are connected by a series of alternating intracellular and extracellular loops. These loops are targets for a host of modifying proteins, including beta  subunits, G-proteins, calmodulin, and syntaxin, as well as the peptide toxins of venomous spiders and marine snails (Catterall, 2000). Interaction of these proteins with alpha 1 subunits typically alters the voltage dependency and kinetics of channel gating, which in turn modifies Ca2+ entry into neurons.

Ultimately, gating behavior is determined by the interactions of individual amino acid side chains with the electrostatic forces within their microenvironments. This is especially true for the positively charged S4 helical segments that constitute the voltage sensors in Na+, Ca2+, and K+ channels. Biophysical studies have shown that depolarization disrupts S4 side-chain interactions of Shaker K+ channels to the extent that S4 helices rotate 180° along their axes (Cha et al., 1999; Glauner et al., 1999). This motion likely triggers a cascade of side-chain disruptions that ultimately leads to rotation and separation of the intracellular S6 segments that form the K+ channel gate (Bezanilla, 2000). Such a mechanism is supported by recent studies delineating the conformational changes associated with open and closed states of bacterial two-membrane-spanning K+ channels (Jiang et al., 2002b) and is generally applicable to Na+ and Ca2+ channel gating.

Attempts have been made to assign specific gating functions to individual Ca2+ channel homology domains. Early chimera studies indicated that the IS6 segment was critical for setting the rate of fast inactivation (Zhang et al., 1994); however, substitution of IIS6 and IIIS6 of the Cav2.3 channel into the slow inactivating Cav1.2 channel caused a leftward shift in the voltage dependence of inactivation and increased the rate of Cav1.2 channel inactivation to near Cav2.3 rates (Stotz et al., 2000). Effects on gating have been reported for amino acid substitutions in IS3 (Zhong et al., 2001), the I-II linker (Berrou et al., 2001), IIS6 (Stotz and Zamponi, 2001), extracellular linkers IIIS3-S4 (Lin et al., 1997), and IVS3-S4 (Hans et al., 1999), and IVS6 (Berjukow et al., 2001). Additive effects on Cav1.2 channel inactivation were reported recently for individual IS6, IIS6, IIIS6, and IVS6 substitutions (Shi and Soldatov, 2002). Together, these data support a structural model of alpha 1 subunits in which individual transmembrane segments are interdependently entwined (Horn, 2000).

Our results indicate that this model also applies to beta  subunit interactions with alpha 1 subunit intracellular linkers. We have shown previously that beta 4 subunit alternative splicing had alpha 1 subtype-specific effects on voltage-dependent activation and inactivation (Helton and Horne, 2002). In this report, we extend these findings to include effects on slow inactivation and block by omega -conotoxin (CTx)-MVIIC; we also identify a proline-rich motif in beta 4b that is responsible for the observed differences in effects.


    MATERIALS AND METHODS

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Deletion mutants. Truncation of the beta 4b N terminus in 10 aa increments was performed using PCR and custom oligonucleotide primers [Integrated DNA Technologies (IDT), Coralville, IA]. All nucleotide and amino acid positions for primers and restriction enzymes correspond to the beta 4b sequence (GenBank accession number U95020). Each forward primer sequence contained an idealized Kozak (1991) sequence and start codon corresponding to the beginning of each of the deleted 10 amino acids as follows: beta 4b Delta 1-10F, 5'-GCCACCATGACCGCGGACGGGCCG; beta 4b Delta 1-20F, 5'-GCCACCATGCAGGTGGCCCGAGGC. Both reactions included a common beta 4 reverse primer, beta 4b 732R (5'-TGACGGCCCCACTAACACC). Full-length beta 4b was used as the template for these reactions. The beta 4b Delta 10-20 deletion mutant was generated with the primer beta 4b Delta 10-20F (5'-GCCACCATGTCCTCCTCCTCCTACGCCAAGAACTCG) paired with beta 4b 732R using the beta 4b Delta 1-20 mutant as the template. Annealing temperature for PCR was 56°C with Gene Choice Taq DNA polymerase (PGC Scientific, Durham, NC). Correctly sized PCR fragments were cloned into the pT-Advantage vector (Clontech, Palo Alto, CA). PCR-based cycle sequencing (FS chemistry; Applied Biosystems, Foster City, CA) was used with an ABI Prism 310 Genetic Analyzer. The data were analyzed using ABI Prism DNA sequencing software (version 2.12; PerkinElmer Biosystems), and sequence alignments and restriction maps were generated using Lasergene Software (DNA Star, Madison, WI). Correct clones were digested with BamHI (Roche Molecular Biochemicals, Indianapolis, IN), and the corresponding ~530 bp fragments were ligated into BamHI (nucleotide position 550) -digested beta 4b in pBluescript II S/K+ (Stratagene, La Jolla, CA). Each beta 4b deletion mutant was sequenced to confirm correct reading frame and proper N-terminal orientation.

Site-directed mutagenesis. For all beta 4b site-directed mutants, full-length beta 4b cDNA (U95020) was used as the template unless otherwise indicated. All site-directed mutagenesis reactions were performed using a QuikChange site-directed mutagenesis kit (Stratagene) and custom forward and reverse compliment oligonucleotide primers (IDT): beta 4bG10A,D13A, 5'-ACGCCAAGAACGCGACCGCGGCCGGGCCGCAC; beta 4bP15A,P18A, 5'-GCGGACGGGGCGCACTCCGCCACCTCGCAGGTG; beta 4bG10A,D13A,P15A,P18A, 5'-ACGCCAAGAACGCGACCGCGGCCGGGGCGCAC (beta 4bP15A,P18A used as template); beta 4bG10A,P15A, 5'-TACGCCAAGAACGCGACCGCGGACGGGGCGCACTCCCCCACCTCGCAGGTG; beta 4bH16A, 5'-ACCGCGGACGGGCCGGCCTCCCCCACCTC; beta 4bG10A,P18A, 5'-TACGCCAAGAACGCGACCGCGGACGGGCCGCACTCCGCCACCTCGCAGGTG;beta 4bD13A,P15A, 5'-TACGCCAAGAACGGGACCGCGGCCGGGGCGCACTCCCCCACCTCGCAGGTG; beta 4bD13A,P18A, 5'-TACGCCAAGAACGGGACCGCGGCCGGGCCGCACTCCGCCACCTCGCAGGTG;beta 4bH16A, 5'-ACCGCGGACGGGCCGGCCTCCCCCACCCTCG; and beta 4bT11A,S17A,T19A,S20A, 5'-CAAGAACGGGGCCGCGGACGGGCCGCACGCCCCCGCCGCGCAGGTGGCC. Each of the mutant clones was sequenced to confirm reaction fidelity.

Electrophysiology. cRNAs were synthesized in vitro using an mMessage mMachine RNA transcription kit from Ambion (Austin, TX) (T3 or T7 depending on clone orientation in pBluescript II S/K+). Standard Xenopus laevis oocyte expression methods were used to characterize beta  deletion and site-directed mutants. Briefly, full-length alpha 1, alpha 2/delta -1, and beta 4 cRNAs were injected in equimolar ratios (5.6 ng of alpha 1A, 2.4 ng of alpha 2/delta -1, and 1.6 ng of beta 4 in 46 nl) into defolliculated oocytes (stage V-VI). The BI-2 (alpha 1A) and alpha 2/delta -1 clones used in this study were provided by T. Tanabe (Tokyo Medical and Dental University, Tokyo, Japan). Calcium channel currents were recorded 2-4 d after oocyte injection by standard two-electrode voltage clamp using a Warner amplifier (OC-725B) at 20-22°C, and data were collected using pClamp6 software (Axon Instruments, Foster City, CA). Microelectrodes were filled with M KCl, and the resistances of the current and voltage electrodes were 0.3-1.5 MOmega . Data were filtered at 2 kHz and sampled at 10 kHz. Currents were recorded in a chloride-free bath containing (in mM): 5 Ba(OH)2, 5 HEPES, 85 TEA-OH, and 2 KOH, pH adjusted to 7.4 with methanesulfonic acid. In experiments with the peptide toxin omega -CTx-MVIIC (Peptide Institute Inc. Osaka, Japan), the 5 mM Ba2+ solution was supplemented with 0.1 mg/ml cytochrome c to saturate nonspecific peptide binding sites. Cytochrome c at 0.1 mg/ml had no noticeable effect on recorded Ba2+ currents. Peptides were reconstituted according to the manufacturer's instructions (100 µM stock solutions in sterile, deionized water). Fresh dilutions of the peptide were made immediately before use. Currents typically ranged between 0.8 and 2.5 µA, and leak currents were between 20 and 100 nA. Data were analyzed using pClamp6 software (Axon Instruments) and Excel 7.0 (Microsoft Corp., Redmond, WA). The leak and capacitive currents were subtracted on line using a standard P/4 protocol. Curve fitting was performed with SigmaPlot version 5.0 (SSPS Inc., Chicago, IL).

Slow inactivation. Oocytes were held at -80 mV for ~2 min before a 300 msec reference pulse (IR) to 0 mV (beta 4b) or +10 mV (beta 4a). After IR, the membrane potential was stepped immediately to a conditioning pulse potential ranging from -100 mV to -20 mV (20 mV increments) and held for 5 min. During the conditioning pulse, a 300 msec test pulse (IT) to 0 mV (beta 4b) or +10 mV (beta 4a) was applied every 15 sec. Data were normalized as the ratio of the maximum current at time T (IT) divided by the maximum reference current (IR). Data were fit to the double-exponential equation IT/IR = A1e-x/tau 1 + A2e-x/tau 2, where IT equals current at time T, IR equals maximum reference current, x equals time in seconds, and A1 and A2 are components for the time constants tau 1 and tau 2, respectively. The SEM is shown for each data point unless the values are smaller than the symbol.

Recovery from slow inactivation. Currents were stabilized at -80 mV or -100 mV for ~2 min before a 300 msec reference pulse (IR) to 0 mV (beta 4b) or +10 mV (beta 4a). After a 100 msec step to either -80 mV or -100 mV, the oocytes were held at a conditioning pulse potential of -30 mV for 5 min. Immediately after the conditioning pulse, a 300 msec test pulse was applied (I1), and then the holding potential was stepped back to either -80 mV or -100 mV and 300 msec test pulses (I2-12) were applied at 15 sec intervals starting at time 0 for a total of 3 min. Data were normalized as the ratio of the maximum current at time T (IT) divided by the maximum reference current (IR). Data were fit to the single exponential equation IT/IR = Iinfinity  + Ae-x/tau , where IT equals current at time point T, IR equals maximum reference current, Iinfinity equals current remaining at end of protocol, x equals time in seconds, and A is the component for the time constant tau .

Voltage dependence of activation and inactivation. Voltage dependency of activation data was generated from I-V curves. Maximal currents were obtained from 300 msec depolarizations from a holding potential of -80 mV to various test potentials (-40 to +10 mV in 5 mV increments). Each individual recording was then normalized, inverted, and fit to the Boltzmann equation %IBa = 1/[1 + exp(-(Vtest - V1/2)/k)], where Vtest equals I-V test potential, Vpre equals prepulse potential, V1/2 equals midpoint of activation or inactivation, and k equals slope factor. The fit curves, V1/2, and k values were then averaged and plotted as a function of membrane voltage.

Voltage dependency of inactivation data was obtained from peak currents elicited by a 300 msec maximal current test depolarization after a 20 sec conditioning prepulse to voltages ranging from -80 to +20 mV. Each individual recording was then normalized and fit to the Boltzmann equation %IBa = 1/[1 + exp([Vpre - V1/2]/k)], where Vtest equals I-V test potential, Vpre equals prepulse potential, V1/2 equals midpoint of activation or inactivation, and k equals slope factor. The fit curves, V1/2, and k values were then averaged and plotted as a function of prepulse potential.

Pharmacology. Oocytes were held at a potential of -80 mV with maximal currents elicited by 150 msec test pulses to 0 mV (beta 4b) or +10 mV (beta 4a) every 15 sec for a total of 10 min. During recordings, oocytes were perfused at a constant rate of ~0.5 ml/min. Average current sizes for beta 4a and beta 4b complexes were 1.9 ± 0.2 µA (4-5 d of incubation) and 2.3 ± 0.3 µA (2-3 d of incubation), respectively. The data were fit to the single-exponential equation IT/IR = Iinfinity  Ae-x/tau , where IT equals maximum current at time point T, IR equals maximum current at time point 0, Iinfinity equals residual current at end of protocol, x equals time in seconds, and A is the component for the time constant, tau . The averaged rate constants (1/tau ) for the four omega -CTx-MVIIC concentrations (0.2, 0.6, 2, and 6 µM) were plotted as a log function of their concentration and were fit well by the equation (tau )-1 = kon[Tx] + koff.

Northern blot analysis. A commercially available human neuronal tissue Northern blot [Multiple Tissue Northern (MTN) Blot brain II; Clontech] was probed with a nonspecific beta 4 subunit probe (beta 4Delta N; nucleotides 215-1628 plus ~300 bp of 3' untranslated). A 32P-labeled beta 4 subunit probe was made with a nick translation kit (Promega, Madison, WI) using the beta 4Delta N mutant as the template. The beta 4Delta N mutant is missing the first coding 147 bp corresponding to the 49 aa N terminus of beta 4 [clone from Helton and Horne (2002)]. The MTN blot was hybridized overnight at 42°C in hybridization buffer [5× SSC, 5% w/v blocking reagent (Roche), 0.1% N-lauroylsarcosine, 0.02% w/v SDS, 50% w/v formamide] plus 100 µg/ml herring sperm DNA (Promega). The probe concentration was 1 million counts/ml. The blot was washed with successive stringency washes (four washes, 15 min each at 37°C) ranging from 2× SSC/0.1% SDS to 0.1× SSC/0.1% SDS. The blot was then exposed to radiographic film for 12 hr at -80°C. One microgram of cRNA for both beta 4a and beta 4b was run out on a 1% denaturing formaldehyde gel along with a poly(A)-tailed cRNA mass ladder (RNA Molecular Weight Marker 1; Roche). The beta 4a cRNA is longer than the beta 4b cRNA because of the additional ~400 nt of 5' untranslated sequence.

Molecular modeling. The sequences for rat postsynaptic density-95 (PSD-95) (DLG4_rat) and human beta 4 (CACNB4) were obtained (accession numbers P31016 and U95020) from the Swiss-prot database. Amino acids 10-96 of beta 4b were aligned to residues 303-390 of PSD-95 based on secondary structure prediction (nnPredict) and visual inspection. For beta 4a, amino acids 50-96 of beta 4b were aligned to residues 345-390 of PSD-95. Using default parameters, the program MODELLER 6 (Sali and Blundell, 1993) was used to produce 50 models each of beta 4b and beta 4a structure based on the solved structure of the third PSD-95/Discs large/zona occludens-1 (PDZ) domain of PSD-95 (1BEF). Five models each were chosen for additional analysis based on the molecular probability density function (PDF) output from MODELLER and stereochemical analysis obtained through Ramachandran output from PROCHECK-NMR (Laskowski et al., 1993). The interactions between different atom types within these models and Calpha root mean square deviation (RMSD) comparisons between the models and 1BEF were characterized with ERRAT (Colovos and Yeates, 1993). The beta 4a and beta 4b models chosen for comparison had the fewest disallowed residues (Ramachandran), lowest molecular PDF and RMSD values, and highest percentage of residues in acceptable conformations based on ERRAT and PROCHECK-NMR analysis. Models were visualized with the program MOLMOL (Koradi et al., 1996).


    RESULTS

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Alternative splicing of the beta 4 subunit affects slow inactivation of Cav2.1 Ca2+ channels

In a previous study (Helton and Horne, 2002), we showed that Cav2.1 complexes containing the longer form of an alternatively spliced beta 4 subunit N terminus, beta 4b (49 aa), inactivated at more negative potentials in response to 20 sec conditioning prepulses than complexes containing a shorter form, beta 4a (15 aa). To determine whether this response extended to slower types of inactivation, we examined in the present study the effects of beta 4a and beta 4b on Cav2.1 cumulative inactivation elicited by 5 min conditioning prepulses combined with stimulation at 0.25 Hz. Oocytes were stabilized at -80 mV before a 300 msec reference pulse (IR) to potentials that were predetermined to give peak inward currents (beta 4b, 0 mV; beta 4a, +10 mV). The membrane potential was then stepped to and held at the conditioning prepulse potential (ranging from -100 to -20 mV) for 5 min. A 300 msec test pulse (IT) was elicited from the conditioning prepulse potential every 15 sec (I5 equals test pulse at 5 min). The kinetics of entry to slow inactivation for Cav2.1 complexes containing either beta 4a or beta 4b at -40 mV is shown in Figure 1A. For comparison purposes, we fit the data points for both beta 4a and beta 4b to two exponentials (smooth curves in the figure). The time constants for the fast component of entry (tau 1) for beta 4a and beta 4b were 28.6 ± 2.6 and 18.9 ± 1.2 sec, respectively, and the time constants for the slow component of entry (tau 2) were 769 ± 23.6 and 384 ± 14.8 sec, respectively. Overall, the IT/IR ratio for Cav2.1 complexes containing beta 4b decreased to 0.5 in ~70 sec, whereas those containing beta 4a required ~380 sec (data not shown). This indicated that beta 4b caused a more than fivefold acceleration of the kinetics of slow inactivation. Representative current traces for reference and 5 min test pulses from a conditioning potential of -40 mV for Cav2.1 complexes containing beta 4a (top) and beta 4b (bottom) are shown in Figure 1B. As seen in the figure and as described in our previous study, Cav2.1 complexes containing beta 4a underwent open-state fast inactivation faster than did complexes containing beta 4b. After 5 min at -40 mV, the rate of fast inactivation was unaltered for complexes containing beta 4a, and slowed only somewhat for complexes containing beta 4b. The absence of any appreciable tail-current indicated that deactivation was not affected by prolonged depolarization. The I5/IR ratio is plotted against the range of conditioning potentials (-100 to -20 mV) in Figure 1C. The figure illustrates that the voltage dependence of Cav2.1 slow inactivation is shifted to the left for complexes containing beta 4b relative to those containing beta 4a. Half-maximal inactivation occurred at approximately -50 mV for complexes containing beta 4b and -35 mV for beta 4a. These values are ~10 mV (beta 4b) and 5 mV (beta 4a) more negative than were determined for inactivation in response to 20 sec conditioning prepulses (Helton and Horne, 2002). Figure 1D shows that recovery from 5 min of slow inactivation at -30 mV is nearly complete when the membrane potential is stepped back to -80 mV, and that there is no difference in the time course of recovery for Cav2.1 complexes containing either beta 4a or beta 4b. Recovery was somewhat faster and more complete when the membrane potential was stepped back to -100 mV. The recovery data at both potentials fit well to single exponentials. The time constants for recovery for beta 4a and beta 4b at -80 mV were 28.6 ± 2.0 and 27.8 ± 1.6 sec, respectively, and at -100 mV, 18.9 ± 0.5 and 17.2 ± 0.4 sec, respectively.



View larger version (30K):
[in this window]
[in a new window]
 
Figure 1.   Effects of beta 4a and beta 4b on slow inactivation and recovery from slow inactivation of Cav2.1 Ca2+ channels. Studies were performed with Xenopus oocytes expressing alpha 1A, alpha 2/delta -1, and either beta 4a or beta 4b. Reference (IR) and test current (IT) traces were generated by 300 msec step depolarizations from various holding potentials to either 0 mV (beta 4b) or +10 mV (beta 4a). Maximum values from 300 msec IR and IT current traces were used to calculate IT/IR where indicated. Barium (5 mM) was used as the charge carrier. A, Influence of beta 4a and beta 4b on the development of slow inactivation at a conditioning potential (CP) of -40 mV. After a reference pulse (IR) measured from a holding potential of -80 mV, oocytes were held at -40 mV for 5 min. During this time, 300 msec test pulses (IT) were applied every 15 sec. Each point represents the mean value of IT/IR from 11 (beta 4a) or 10 (beta 4b) different recordings. The SEM is shown for each point unless the values were smaller than the symbol. The solid lines represent double-exponential fits to the data. B, Representative reference (IR) and 5 min (I5) current traces from Cav2.1 complexes containing either beta 4a (top) or beta 4b (bottom) generated as described in A. C, Voltage dependence of slow inactivation. The ratio of I5 to IR, generated as in A, plotted as a function of conditioning potential for Cav2.1 complexes containing either beta 4a or beta 4b. Data points represent the means of at least six determinations at a given membrane potential. Lines serve only to connect the data points. D, Influence of beta 4a and beta 4b on the time course of recovery from slow inactivation. After a 300 msec reference pulse (IR) measured from a holding potential of either -80 or -100 mV, oocytes were held at -30 mV for 5 min. The membrane potential was then returned to either -80 or -100 mV, and sequential test pulses (IT) were applied at 15 sec intervals for a total of 3 min. Each point represents the mean of at least seven different recordings. Solid lines represent the single-exponential fits of the data.

Alternative splicing of the beta 4 subunit affects omega -CTx-MVIIC block of Cav2.1 Ca2+ channels

The results to this point indicate that changes in the structure of the beta 4 subunit N terminus impact alpha 1A subunit structures that are important for many aspects of gating, including activation, open-state inactivation, and fast and slow closed-state inactivation. Given that recent evidence indicates that cytosolic determinants of two-membrane-spanning K+ channel gating are coupled to changes in outer vestibule structure (Perozo et al., 1999; Jiang et al., 2002a,b), we next sought to determine whether alternative splicing of the beta 4 subunit would affect the block of Cav2.1 channels by a marine snail peptide conotoxin, omega -CTx-MVIIC. Conotoxin interactions with voltage-gated Ca2+ channels are entirely extracellular and occur through binding sites located near H5 (P) helices in several of the six helix transmembrane-spanning motifs (Ellinor et al., 1994). Figure 2A shows the effects of 2 µM omega -CTx-MVIIC on Cav2.1 Ca2+ channel complexes expressed in Xenopus oocytes in the presence of either beta 4a or beta 4b. The oocytes were held at -80 mV for 10 min and stimulated every 15 sec. Under these conditions, omega -CTx-MVIIC associated with Cav2.1 complexes containing beta 4b at a faster rate (tau  = 50 ± 0.75 sec) than complexes containing beta 4a (tau  = 200 ± 16 sec). The loss of Ca2+ current resulting from slow inactivation over 10 min at -80 mV (<15%) was subtracted from the data plotted in the figure. Figure 2B demonstrates that as expected for a first-order reaction, the rate constants (tau -1) for toxin block were linearly dependent on toxin concentration as described by the equation (tau )-1 = kon [Tx] + koff. Slopes of linear fits to the data for Cav2.1 complexes containing either beta 4a and beta 4b were 3.7 × 10-6 M-1 · sec-1 and 1.1 × 10-5 M-1 · sec-1, respectively. This indicated that the on-rate (kon) for toxin block was approximately threefold faster for Cav2.1 complexes containing beta 4b than for those containing beta 4a.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 2.   Effects of beta 4a and beta 4b on the blockade of Cav2.1 channels by omega -CTx-MVIIC. Studies were performed with Xenopus oocytes expressing alpha 1A, alpha 2/delta -1, and either beta 4a or beta 4b. A, Onset and degree of block by a 10 min exposure to 2 µM omega -CTx-MVIIC for Cav2.1 subunit combinations at a holding potential (HP) of -80 mV. Each point represents the mean of seven (beta 4a) or eight (beta 4b) different recordings. The SEM is shown for each data point unless smaller than the symbol. Onset of block for both subunit combinations was fit (line) to a single-exponential time course plus a constant. B, The rate constants for the time course of the onset of toxin block were determined from steady-state degree of block from single exponential fits at four different toxin concentrations (0.2, 0.6, 2, and 6 µM) for Cav2.1 complexes containing either beta 4a or beta 4b. The averaged rate constants were plotted as a function of toxin concentration (minimum of n = 7, ±SEM). The line represents a linear fit to the data.

The molecular determinants of alternatively spliced beta 4 subunit differential effects on gating and pharmacology are located within amino acids 10-20 of beta 4b

Having characterized many of the functional consequences of alternative splicing of the beta 4 A domain, we focused next on identifying the key structural determinants underlying the observed differences in effects. It was of particular interest to determine whether or not the effects of alternative splicing on gating and pharmacology could be assigned to separate structural entities. To accomplish this, we first created a series of beta 4b deletion mutants in which the N terminus was shortened by multiples of 10 aa (beta 4b Delta 1-10 through beta 4b Delta 1-49) and characterized their effects on gating and pharmacology of Cav2.1 complexes. Figure 3A-D shows that, relative to full-length beta 4b, deletion of the first 10 aa (beta 4b Delta 1-10) had no effect on the voltage dependence of activation (Fig. 3A), isochronal (20 sec prepulse) inactivation (Fig. 3B), onset into slow inactivation (Fig. 3C), or susceptibility to block by 2 µM omega -CTx-MVIIC (Fig. 3D). However, when amino acids 1-20 were removed (beta 4b Delta 1-20), both the voltage dependence of activation (Fig. 3A) and inactivation (Fig. 3B) of Cav2.1 complexes shifted to more depolarized potentials. As shown in the figure, the acquired gating properties were essentially identical those for Cav2.1 complexes containing beta 4a. Cav2.1 complexes containing beta 4b Delta 1-20 also had a slower onset into slow inactivation (Fig. 3C) and were less susceptible to block by 2 µM omega -CTx-MVIIC (Fig. 3D). The effects of constructs beta 4b Delta 1-30, beta 4b Delta 1-40, and beta 4b Delta 1-49 were identical to those of beta 4b Delta 1-20 (data not shown). As a first attempt at determining whether the effects of beta 4b Delta 1-20 were simply the result of a decreased size of the beta 4b N terminus, we reintroduced amino acids 1-10 to the N terminus of beta 4b Delta 1-20 to create the construct beta 4b Delta 10-20. As shown in Figure 3A,B, this did not restore the V1/2 of either activation or inactivation to the hyperpolarized potentials characteristic of Cav2.1 complexes containing beta 4b. Together, these results indicated that the molecular determinants responsible for the observed differences between Cav2.1 complexes containing beta 4a versus beta 4b were located in amino acids 10-20 of beta 4b. Moreover, it was apparent that their influence extended to changes in both gating and pharmacology.



View larger version (38K):
[in this window]
[in a new window]
 
Figure 3.   Localization of differential effects on Cav2.1 gating and pharmacology to beta 4b N-terminal amino acids 10-20. The first 10 (beta 4b Delta 1-10), first 20 (beta 4b Delta 1-20), or second 10 (beta 4b Delta 10-20) aa of the N terminus of the beta 4b subunit were removed using PCR. The deletion mutants as well as beta 4a or beta 4b were expressed with alpha 1A and alpha 2delta -1 in Xenopus oocytes. A, Effects of the N-terminal deletion mutants on the voltage dependency of activation of Cav2.1 channels. Plots were derived from averaged I-V data up to +10 mV for each beta 4 subunit combination. Data points represent the means of the normalized data at a given membrane potential for a minimum of nine different recordings. Smooth lines represent single Boltzmann fits to the averaged data. B, Normalized, averaged isochronal inactivation curves for Cav2.1 complexes containing the various beta 4 subunits. Points represent the means of the normalized data at a given membrane potential for a minimum of nine different recordings. Smooth lines represent single Boltzmann fits to the averaged data. C, Effects of beta 4 N-terminal deletion mutants on the development of slow inactivation at a conditioning potential (CP) of -40 mV. Reference (IR) and test (IT) currents were generated as in Figure 1A. Each point represents the mean value of IT/IR from 13 (beta 4b Delta 1-10) or nine (beta 4b Delta 1-20) different recordings. The solid lines represent double-exponential fits to the data. D, Onset and degree of block by a 10 min exposure to 2 µM omega -CTx-MVIIC for Cav2.1 complexes containing beta 4b Delta 1-10 or beta 4b Delta 1-20. Data were generated as in Figure 2A. Each point represents the average of a minimum of seven recordings. The solid lines represent single-exponential fits to the data.

The beta 4 A domain is a distant homolog of the third PDZ domain of PSD-95

With the results of the deletion experiments highlighting a specific location for the molecular determinants of beta 4b gating and pharmacology effects, and with the observation that the beta 1b A domain resembles PDZ domains (Hanlon et al., 1999), we began a systematic comparison of the beta 4b sequence with similar regions of a number of PDZ domains. Unexpectedly, we found that the entire beta 4b A domain was weakly homologous to the third PDZ domain of PSD-95 (Fig. 4A). Of the 87 aa that have been shown by x-ray crystallography to form the modular PDZ structure of PSD-95 (Doyle et al., 1996), 27 of these (~31%) are conserved in the beta 4b sequence. Most importantly, these identities are conserved within key secondary structural elements, such as beta -strand C and alpha -helix 2 of PSD-95. Also of note is the conservation of an RG(S/T)T motif in what would be the equivalent of the carboxylate binding loop (CBL) between beta -strands A and B of PSD-95 and the loss of the GLGF motif that is extremely common among PDZ domain subtypes (Bezprozvanny and Maximov, 2001; Harris and Lim, 2001). Four of beta 4b amino acids 10-20 (G10, D13, P15, and P18) were found in PSD-95. We used these as a starting point for further defining key beta 4b residues involved in setting Cav2.1 gating parameters.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 4.   The beta 4 subunit is a distant homolog of PSD-95. Identification of a conserved GXXDXPXXP motif critical to Cav2.1 gating. A, Amino acid alignment of the A domains of the human spinal cord beta 4a (amino acids 1-63) and beta 4b (amino acids 1-97) subunits with the third PDZ domain (amino acids 294-391) of PSD-95. Vertical bars denote identical amino acids between beta 4b and PSD-95. Important amino acids involved in modulating the leftward shift in the voltage dependence of activation and inactivation of beta 4b (GXXDXPXXP) are highlighted. Arrows and hatched bars represent predicted alpha -helices and beta -strands of the third PDZ domain of PSD-95, respectively. B, Differences in the V1/2 values of activation and inactivation of beta 4a, beta 4b, and beta 4b N-terminal amino acid mutants. Solid bars represent average V1/2 values of a minimum of nine different recordings for each beta 4 subunit variant. Positive or negative shifts in the V1/2 values (in millivolts) of activation and inactivation of beta 4a and beta 4b mutants are relative to the V1/2 values of activation and inactivation of beta 4b. Currents were generated as described in Figure 3, A and B. The SEM for each bar is shown. Asterisks denote statistical significance (p < 0.05) by a Student's two-sample equal variance t test.

Figure 4B lists a series of site-directed mutants (left), along with their effects on the voltage dependence (V1/2) of activation (middle) and inactivation (right) of Cav2.1 complexes. The V1/2 values for complexes containing beta 4a and beta 4b are included for comparison. Interestingly, the first site-directed beta 4b mutant tested, G10A, D13A, P15A, P18A, in which all four of the amino acids in common with PSD-95 were altered, displayed activation and inactivation properties similar to that of beta 4a. To determine whether this was a specific effect, we altered four different amino acids in the beta 4b 10-20 sequence to create the mutant, T11A, S17A, T19A, S20A. As shown in Figure 4B, Cav2.1 gating properties changed little in response to these mutations. Cav2.1 complexes containing the G10A, D13A, P15A, P18A mutant also had beta 4a-like slow inactivation and pharmacological properties (data not shown). This indicates that the conserved amino acids are playing a defining role in the gating motif. To delineate the structure in more detail, we subsequently characterized six of the possible G10, D13, P15, P18 amino acid pairs for their effects on gating. Surprisingly, none of the pairs were absolutely essential for maintaining wild-type beta 4b gating behavior, although small but statistically significant hyperpolarizing effects on activation were noted for five of the six pairs. To complete the alanine substitution study, we created the mutant H16A, which had a small but statistically significant effect on inactivation but not activation.

One interpretation of these results is that beta 4b amino acids 10-20 form a ligand motif that interacts with a binding pocket located somewhere either on the alpha 1A subunit or on the beta 4 subunit itself. The affinity of the ligand motif for its receptor site could be defined, for example, by the sum of the interactions of amino acids G10, D13, P15, and P18 with their individual targets. Any given pair may be capable of maintaining a binding interaction under the conditions of our experiments. As a first step toward addressing this possibility, we created three-dimensional structural models of the beta 4a and beta 4b A domains (Fig. 5A,B) using the real-space optimization method used in the computer program MODELLER (Sali and Blundell, 1993). The models were initiated using the distance and dihedral angle restraints derived from alignments with portions of the sequence of the third PDZ domain of PSD-95. For beta 4b, amino acids 10-96 were aligned with amino acids 303-390 of PSD-95. There is 31% sequence identity over this region, which is considered minimally acceptable for this type of comparative modeling (Martí-Renom et al., 2000). For beta 4a, amino acids 10-49 of beta 4b were deleted from the alignment. Thus, the models do not include the first 15 aa of beta 4a and the first 9 aa of beta 4b. Figure 5A (left) shows that beta 4a models as a compact structure containing three beta -sheets and 2 alpha -helices. Stereochemical quality assessment of the model using PROCHECK-NMR (Laskowski et al., 1993) identified 41 residues (87.7%) in most favored regions, 5 (10.6%) in additional and generously allowed regions, and 1 (2.1%) in a disallowed region. Calculation of the electrostatic surface potential using MOLMOL (Koradi et al., 1996) reveals that the face of the molecule as oriented in Figure 5A, left, contains a pocket of negative charge (red residues) between the two alpha -helices (Fig. 5A, right). Figure 5B, right and left, illustrates that the overall effect of alternative splicing to form beta 4b is to bury the charged pocket beneath three additional beta -sheets. Interestingly, the molecule acquires as the result of splicing a positively charged binding pocket (blue residues) in what would be the equivalent of the CBL in PSD-95 (Fig. 4A). The stereochemical quality of the beta 4b model as shown is not quite as good as that for beta 4a. PROCHECK-NMR identified 64 residues (79%) in most favored regions, 11 residues (13.6%) in additional allowed regions, and 3 residues (3.7%) each in generously allowed and disallowed regions. Two of the three disallowed residues (R30 and K34) flank what would be the equivalent PSD-95 beta -sheet B. Together with the loss of the highly conserved PDZ GLGF sequence, these results are consistent with the notion that through evolution this region of the beta 4b structure has evolved away from the capacity to bind C-terminal peptide motifs. Of most importance to our present results, however, is the observation that beta 4b amino acids 10-20 model as an extended arm (pointing to the left in Fig. 5B, right, left) that may serve as a ligand motif. Interestingly, the orientation of the arm appears to be dictated by the isomerization state of proline18 (data not shown).



View larger version (34K):
[in this window]
[in a new window]
 
Figure 5.   Real-space optimization structural models of the A domains of beta 4a (A) and beta 4b (B) based on sequence identities with the third PDZ domain of PSD-95. Ribbon (left) and electrostatic surface potential (right) diagrams were created using MOLMOL (Koradi et al., 1996). For ribbon diagrams, arrows indicate beta -strands, and helices indicate alpha -helices. For surface potential diagrams, red, white, and blue regions indicate negatively charged, hydrophobic, and positively charged amino acids, respectively.

Differential distribution of alternatively spliced beta 4 subunit mRNA

We noted in our previous study (Helton and Horne, 2002) that, based on extensive cDNA library screening, beta 4a was the predominant alternatively spliced variant of the beta 4 subunit expressed in human spinal cord. To confirm this observation, we performed a comparative Northern blot analysis using a commercially available multiple tissue Northern blot (Human Brain II; Clontech) and a beta 4 cDNA probe containing sequence common to both beta 4a and beta 4b. The mRNAs for beta 4a and beta 4b can be readily distinguished by their distinct migration pattern in agarose-formaldehyde gels (Fig. 6A). The results of the Northern blot analysis, shown in Figure 6B, were striking, revealing that not only was beta 4a the predominant form of beta 4 subunit in the spinal cord, but also in other "reptilian" portions of the human CNS such as the medulla and putamen. Moreover, beta 4a was the predominant form of beta 4 subunit expressed in evolutionarily older regions of the cerebrum, the temporal lobe, and occipital pole. In marked contrast, beta 4b was highly expressed in the most recent and most highly integrative region of the cerebrum, the frontal lobe. The two forms of the beta 4 subunit were equally expressed in the cerebellum.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 6.   Differential distribution of beta 4a and beta 4b mRNA in the human CNS. A, Electrophoresis of full-length beta 4a (left) and beta 4b (right) cRNAs (includes 5' and 3' untranslated) in a 1% agarose formaldehyde denaturing gel. RNA markers (in kilobases) are indicated on the left. B, Northern blot analysis performed with human multiple tissue blot (Human Brain II; Clontech) and a 32P-labeled beta 4 subunit probe (coding nucleotides 215-1628 plus ~300 bp 3' untranslated sequence). Molecular masses on the right correspond to labeled blot markers. C, A human beta 4 subunit genome map depicting the lengths of intron sequences (b, bases) between alternatively spliced beta 4a and beta 4b N-terminal exons and the beginning of exon 2. Solid lines represent exons, and dashed lines represent introns. Numbers in parentheses below solid lines indicate position on chromosome 2. Boxes indicate protein sequence (beta 4a in parentheses). The first and last two amino acids of each sequence are indicated above each box.

A basic local alignment search tool search of the human genome (Altschul et al., 1990) with beta 4 sequences revealed that the exons coding for alternatively spliced forms of the beta 4 subunit A domain are distributed widely on human chromosome 2. Figure 6C shows that, depending on the splice variant, the coding sequence for the beta 4 PDZ domain is contained within three (beta 4a) or four (beta 4b) exons spread out over ~218,000 bases. The coding sequence for the GXXDXPXXP motif is included in the 5'-most exon of a pair of short exons that code for beta 4b amino acids 1-49. Assembly of the beta 4b mRNA requires that three RNA segments (536 bases, 214,959 bases, and 2329 bases) be spliced out. The short exon coding for the first 15 aa of beta 4a lies between the beta 4b N-terminal exons and the exon coding amino acids 50-89 and 16-55 of beta 4b and beta 4a, respectively. By comparison, the third PDZ domain of PSD-95 is encoded by two exons separated by a 200 bp intron (data not shown).


    DISCUSSION

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We have identified an alternatively spliced proline-rich motif in the Ca2+ channel beta 4 subunit that has considerable influence over gating of neuronal Cav2.1 Ca2+ channels. Given that the motif also affects extracellular toxin binding, it is likely that the interaction of this motif with its binding site has wide-reaching impact on resting and open-state Ca2+ channel conformations. This notion is supported by recent images of the conformational changes that occur with gating of bacterial two-membrane-spanning K+ channels (Liu et al., 2001; Jiang et al., 2002a,b). Like eukaryotic six-membrane-spanning K+ channels, KcsA and MthK channels are tetramers that pack with fourfold symmetry around a central pore (Doyle et al., 1998; Jiang et al., 2002a). The principal structural elements of KcsA and MthK from N to C terminus include an outer transmembrane helix (M1), a pore helix (P), and an inner transmembrane helix (M2). These correspond to S5, H5, and S6 segments of voltage-gated Ca2+ channels, respectively. In the closed conformation of the KcsA structure, the four M2 helices are straight and arranged such that they form the walls of an inverted teepee that narrows from a 12 Å diameter at its center to a 4 Å pore at its tip (Doyle et al., 1998). After opening, the KcsA M2 helices tilt away from the permeation pathway and rotate about their helical axis (Liu et al., 2001). In MthK, bending and splaying of the inner helices after opening expands the diameter of the pore threefold (Jiang et al., 2002a,b). The nearly 30° bend occurs at a "gating hinge" corresponding to a glycine residue just below the selectivity filter. Applying a radial-outward force on the intracellular aspects of the inner helices places a torque on the gating hinge such that a conformational change is transmitted the full length of the M2 helix. This results in a widening of the outer vestibule [Jiang et al. (2002b), see supplementary information (movie)]. It is has been hypothesized that similar mechanical forces are at work in the gating of voltage-gated Ca2+ channels (Jiang et al., 2002b).

Considered in the context of this mechanical framework, our results suggest that an interaction of the beta 4b ligand motif with an inner aspect of the Cav2.1 complex either directly or indirectly fine-tunes the torque experienced by alpha 1A S6 segments. In so doing, the interaction alters the conformation of the voltage sensor or gate (or both) as well as the outer vestibule. This would explain why alternative splicing of the beta 4 subunit would affect both gating and toxin sensitivity. Given the potential for the ligand motif interaction to occur over a wide range (Helton and Horne, 2002), it is not possible from our results to pinpoint which S6 helices might be most affected. And although our omega -CTx-MVIIC binding results might be providing some direction, a previous study has shown that omega -CTx-GVIA binding to alpha 1B is affected by alterations in any of the four P loops that make up the outer vestibule (Ellinor et al., 1994). A case can be made for an indirect effect on the IS6 helix, because the primary alpha 1-beta 4 subunit interaction occurs on the intracellular loop between homology domains I and II (I-II loop) (Pragnell et al., 1994). This is consistent with a previous study showing that IS6 is a critical determinant of voltage-dependent inactivation in Cav2.1 and Cav2.3 channels (Zhang et al., 1994). However, site-directed mutagenesis and domain-swapping studies have highlighted the equal importance of IIS6, IIIS6, and IVS6 in Ca2+ channel gating (for review, see Stotz and Zamponi, 2001; Shi and Soldatov, 2002), making the case for direct effects on these S6 helices equally plausible. It is interesting that many of the proteins that have evolved to modulate Ca2+ channel gating target alpha 1 I-II (beta  subunits, Gbeta gamma subunits, protein kinase C) and II-III loops (syntaxin, synaptotagmin, and synaptosomal-associated protein-25). The IS6 and IIS6 (but not IIIS6 or IVS6) helices of Cav2.1, 2.1, and 2.3 Ca2+ channels have glycines in hinge positions comparable with those present in KcsA and MthK (see alignments in Horne et al., 1993).

Despite extensive binding studies with beta 4 subunits, there is currently no evidence to support the notion that the beta 4b N terminus binds directly to alpha 1A subunits (Walker et al., 1998, 1999). One possible explanation for this is that the interaction is too weak to be detected in solution binding assays. The other possibility is that the alpha 1A subunit is not the primary binding target. The sequence of the ligand motif (GXXDXPXXP) may provide an important clue as to the nature of its own binding site. Proline-rich motifs are common within the primary structures of many ligands important for protein-protein interactions (for review, see Kay et al., 2000; Ma